8-KEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Oct 18, 2023)

Filed October 18, 2023For Securities:ELV

Summary

Elevance Health, Inc. (ELV) filed an 8-K on October 17, 2023, to report its financial results for the quarter ended September 30, 2023. The primary purpose of this filing is to provide investors with the company's latest financial performance through a furnished press release (Exhibit 99.1). While the 8-K itself doesn't contain the detailed results, it formally announces the availability of this information, allowing investors to access the press release for a comprehensive overview of revenue, earnings, and other key financial metrics for the specified period. This report serves as a notification to the market that Elevance Health has released its quarterly financial update. Investors and analysts should refer to the press release, Exhibit 99.1, for specific figures and management commentary on operational performance, growth drivers, and the company's outlook. The filing also includes standard forward-looking statement disclaimers, advising caution regarding future projections due to inherent business risks and uncertainties in the healthcare industry.

Key Highlights

  • 1Elevance Health filed an 8-K on October 17, 2023, to report Q3 2023 financial results.
  • 2The filing officially disseminates the company's financial performance for the quarter ended September 30, 2023.
  • 3Key financial details and operational updates are provided via an attached press release (Exhibit 99.1).
  • 4Investors are directed to the press release for comprehensive Q3 2023 financial results and commentary.
  • 5The report includes standard forward-looking statement disclaimers regarding potential risks and uncertainties.
  • 6Information furnished under Item 2.02 is not considered 'filed' for Section 18 purposes, limiting liability.

Frequently Asked Questions

The actual financial results for the quarter ended September 30, 2023, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should review this press release for specific figures and management's discussion.

This 8-K filing formally announces the release of Elevance Health's quarterly financial results. It directs investors to the accompanying press release, which contains the detailed financial performance data and insights for the period, fulfilling the company's disclosure obligations.

Yes, the filing includes a section on forward-looking statements. This section outlines potential risks and uncertainties that could cause actual future results to differ materially from management's current expectations. Investors should carefully consider these risks.

No, the information furnished in Item 2.02 of this report, including the press release in Exhibit 99.1, is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, unless expressly stated otherwise.